World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
81
Citations
30882
World Ranking
1552
National Ranking
84

Overview

A. Jon Stoessl is affiliated with the University of British Columbia in Canada and has contributed extensively to the fields of medicine and neuroscience, with a particular focus on neurology and cognitive neuroscience. Their research spans several subfields including cellular and molecular neuroscience, radiology, nuclear medicine and imaging, as well as critical care and intensive care medicine.

Their work primarily addresses topics related to Parkinson's disease mechanisms and treatments, neurological disorders and treatments, and the long-term effects of COVID-19. Additional research interests include neurological diseases and metabolism, botulinum toxin and related neurological disorders, autism spectrum disorder research, and cognitive disorders in intensive care units.

A selection of recent published papers by A. Jon Stoessl includes:

  • "A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria" (2024, The Lancet Neurology)
  • "Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson Disease" (2021, JAMA Neurology)
  • "GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop" (2020, Journal of Parkinson's Disease)
  • "Nigrostriatal tau pathology in parkinsonism and Parkinson's disease" (2023, Brain)
  • "RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses" (2024, The Lancet Neurology)

The scientist has frequently published in venues such as Movement Disorders, The Lancet Neurology, bioRxiv (Cold Spring Harbor Laboratory), Journal of Parkinson's Disease, and npj Parkinson's Disease.

Regular collaborators in their research include Vesna Sossi, William J. Panenka, Cheryl L. Wellington, Ziv Gan-Or, and Martin J. McKeown. Stoessl's work exhibits a significant focus on collaboration within the Parkinson's disease research community.

Best Publications

  • Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology

    Alexander Zimprich;Alexander Zimprich;Saskia Biskup;Petra Leitner;Peter Lichtner

  • A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease†

    C. Warren Olanow;Christopher G. Goetz;Jeffrey H. Kordower;A. Jon Stoessl

  • Expectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson's Disease

    Raúl de la Fuente-Fernández;Thomas J. Ruth;Vesna Sossi;Michael Schulzer

  • Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.

    Anthony E. Lang;Steven Gill;Nik K. Patel;Andres Lozano

  • Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

    Alan L Whone;Ray L Watts;A Jon Stoessl;Margaret Davis

  • Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

    J.A. Obeso;M. Stamelou;M. Stamelou;C.G. Goetz;W. Poewe

  • Double-blind study of botulinum toxin in spasmodic torticollis

    JosephK.C Tsui;A Jon Stoessl;Andrew Eisen;Susan Calne

  • Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

    William J Marks;Jill L Ostrem;Leonard Verhagen;Philip A Starr

  • Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease

    Silke Appel-Cresswell;Carles Vilarino-Guell;Mary Encarnacion;Holly Sherman

  • In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.

    Chong S. Lee;Ali Samii;Vesna Sossi;Thomas J. Ruth

  • Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.

    Matthieu F. Bastide;Wassilios G. Meissner;Barbara Picconi;Stefania Fasano

  • Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias

    Raúl de la Fuente-Fernández;Vesna Sossi;Zhigao Huang;Sarah Furtado

  • Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease.

    D B Calne;J W Langston;W R Martin;A J Stoessl

  • Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease

    Lorraine V. Kalia;Anthony E. Lang;Lili Naz Hazrati;Shinsuke Fujioka

  • Dopamine release in human ventral striatum and expectation of reward.

    Raúl de la Fuente-Fernández;Anthony G Phillips;Mariangela Zamburlini;Vesna Sossi

  • DCTN1 mutations in Perry syndrome

    Matthew J. Farrer;Mary M. Hulihan;Jennifer M. Kachergus;Justus C Dächsel

  • Effects of expectation on placebo-induced dopamine release in Parkinson disease.

    Sarah C. Lidstone;Michael Schulzer;Katherine Dinelle;Edwin Mak

  • PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.

    John R. Adams;Hinke van Netten;Michael Schulzer;Edwin Mak

  • DNAJC13 mutations in Parkinson disease

    Carles Vilariño-Güell;Alex Rajput;Austen J. Milnerwood;Brinda Shah

  • Autosomal dominant parkinsonism associated with variable synuclein and tau pathology

    Zbigniew K. Wszolek;R. F. Pfeiffer;Y. Tsuboi;R. J. Uitti

  • Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.

    Robert A. Hauser;Olivier Rascol;Amos D. Korczyn;A. Jon Stoessl

Frequent Co-Authors

Matthew J. Farrer
Matthew J. Farrer University of Florida
Martin J. McKeown
Martin J. McKeown University of British Columbia
Jeffrey H. Kordower
Jeffrey H. Kordower Arizona State University
Antonio P. Strafella
Antonio P. Strafella University of Toronto
Rosa Rademakers
Rosa Rademakers University of Antwerp
David J. Brooks
David J. Brooks Newcastle University
Elena Moro
Elena Moro Grenoble Alpes University
Catharine A. Winstanley
Catharine A. Winstanley University of British Columbia
Alan Kingstone
Alan Kingstone University of British Columbia
Luke Clark
Luke Clark University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing A. Jon Stoessl

Trending Scientists